Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. In December interim phase 1/2 trial results showed ...

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

Electronic reminders to encourage older adults in Denmark to get vaccinated against flu may have unintentionally lowered ...

Sanofi’s CEO Paul Hudson has courted controversy by saying the French pharma’s potential COVID-19 vaccine will likely be delivered to the US government first should it succeed in clinical trials.

The growth trajectory of the global generic drugs market is underpinned by several key drivers. Firstly, the escalating incidence of chronic and non-chronic diseases worldwide underscores the vital ...

The Republic aims to strengthen its RNA capabilities by providing a platform for key institutions here to collaborate. Read more at straitstimes.com.

Infectious disease outbreaks have a bad habit of piling on at the worst possible times. The 1918 flu pandemic, also known as the Spanish flu, caught the world by surprise just as the First World War ...

The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system.